AxoGen, Inc. Provided revenue guidance for the year 2023. For the full year, the company provides revenue in the range of $154 million to $159 million which represents annual growth of 11% - 15%.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.875 USD | +0.66% | +2.56% | -0.29% |
05-28 | Axogen, Inc. Announces the Opening of its Axogen Processing Center | CI |
05-16 | AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.29% | 299M | |
+6.56% | 217B | |
+11.87% | 190B | |
+19.04% | 143B | |
+29.81% | 111B | |
+0.65% | 64.59B | |
+14.83% | 52.36B | |
+2.06% | 48.45B | |
-5.24% | 38.03B | |
-0.59% | 35.6B |
- Stock Market
- Equities
- AXGN Stock
- News AxoGen, Inc.
- Axogen, Inc. Provides Revenue Guidance for the Year 2023